Fact CheckerSign in

NCT07058389Recruiting

Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.

Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia: a Pilot Study.

Source: ClinicalTrials.gov · Last updated 25 Nov 2025

Brief summary (registry, in English)

Physical activity appears to be a novel and original adjunctive therapeutic approach in the management of patients with schizophrenia. It may help reduce schizophrenic symptoms, act as a pro-cognitive therapy, improve quality of life, and reduce cardiovascular comorbidities. Moreover, some evidence suggests that physical activity practiced in a natural environment has even more positive effects on mental health compared to physical activity carried out indoors or in urban settings. Indeed, greater exposure to greenery is associated with a better perception of general health and with reduced levels of cortisol, anxiety, and depression. No study has yet attempted to examine the impact of physical activity in green (outdoor) spaces compared to indoor physical activity on the negative symptoms of patients suffering from schizophrenia. The aim of this study is therefore to test this hypothesis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
45 (estimated)
First submitted
30 Jun 2025
Start date
7 Oct 2025
Primary completion date
Jun 2027
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
NCT number
NCT07058389

What you commit to

  • Study type: Interventional
  • Planned participants: 45
  • From 7 Oct 2025 to the primary completion date, Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
  • Subject unable to understand the purpose and conditions of the study, unable to give consent.

Other

  • Patient unsuitable for study in the opinion of the investigator
  • Any subject presenting chronic or central neurological pathologies.
  • Any subject deprived of liberty or subject to legal protection
  • Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
  • Pregnant women.

Who the study is looking for

  • Patients with schizophrenia, aged 18 to 55 years
  • Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
  • Regularly monitored in the psychiatry department.
  • Have no medical contraindications to physical activity
  • Subject affiliated with or entitled to a social security system.
  • Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
  • Male or female.

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chu de Saint Etienne
Coordinator of this site? Confirm its status
Saint-EtienneFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.